3rd Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
S. 504 Fair And Immediate Release of Generic Drugs Act S. 214 Preserve Access to Affordable Generics Act generic drug label changes and preemption of federal law
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Health Issues HCR
S. 959, Pharmaceutical Compounding Quality and Accountability Act S. 957, Drug Supply Chain Security Act Issue related to prescription drug abuse, abuse deterrent drug formulations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.